SOTIO

  • Founded in 2010
  • Employees: 300

sotio.com

Description :

SOTIO is a biotechnology company developing a new Active Cellular Immunotherapy (“ACI”) based on activated dendritic cells for the treatment of cancer and autoimmune diseases.

Headquarters :

SOTIO Jankovcova 1518/2 17000 Prague

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and it's freely accessible content.